MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: An impact on susceptibility and prognosis

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1549-1554

  Penna, G ^a   Allegra, A ^a   Alonci, A ^a   Aguennouz, M ^a   Garufi, A ^a   Cannavo A ^a   Gerace, D ^a   Alibrandi, A ^b   Musolino, C ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

B chronic lymphocytic leukemia; Gene polymorphism; MDR1; Prognostic marker

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN VH; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; NEOPLASM STAGING; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84655165078     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9561-9     Document Type: Article

References (37)

1. G Wulf 1994 Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northen blot analysis Leuk Res 18 475 484
2. L Iyer MJ Raain 1998 Pharmacogenetics and cancer chemotherapy Eur J Cancer 34 1493 1499
3. MF Fromm 2002 The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans Adv Drug Deliv Rev 54 1295 1310
4. K Jamroziak T Robak 2004 Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies Hematology 9 91 105
5. C Marzolini E Paulus T Buclin RB Kim 2004 Polimorphorsms in human MDR1 (P-glycoprotein): recent advances and clinical relevance Clin Pharmacol Ther 75 13 33
6. RB Kim 2001 Identification of functionally variant MDR1 alleles among European Americans and African Americans Clin Pharmacol Ther 70 189 199
7. RB Kim 2005 Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in the novo acute myeloid leukemia Int J Cancer 118 2195 2201
8. S Hoffmeyer 2000 Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proc Natl Acad Sci USA 97 3473 3478
9. M Hitzl 2001 The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells Pharmacogenetics 11 293 298
10. M Schaich S Sourcek C Thiede G Ehninger T Ilmer 2005 MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia Br J Haematol 128 324 332
11. DH Kim 2005 Multidrug resistance as a potential prognostic indicator in acute myeoid leukemia with normal karyotypes Acta Haematol 114 78 83
12. M Monzo 2006 Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia Blood 107 4871 4879
13. M Stanulla 2005 GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia Int J Hematol 81 39 44
14. B Van der Holt 2006 ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients Clin Pharmacol Ther 80 427 439
15. G Buda 2007 MDR1 polymorphism influences the outcome of multiple myeloma patients Br J Haematol 137 454 456
16. V Maggini 2008 MDR1 diplotypes as prognostic markers in multiple myeloma Pharmacogenet Genomics 18 383 389
17. DH Kim JY Park SK Sohn NY Lee KB Lee 2006 The association between multidrug resistance-1 gene polymorphisms and outcomes of allogenic HLA-identical stem cell transplantation Haematologica 91 848 851
18. S Dulucq 2008 Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia Blood 112 2024 2027
19. H Zheng 2002 The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in paediatric heart transplant patients Him Immunol 63 765 770
20. TJ Hamblin Z Davis A Gardiner DG Oscier FK Stevenson 1999 Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 94 1848 1854
21. Ni LN et al. Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia. Med Oncol. 2010 Mar 4. [Epub ahead of print].
22. S Turgut A Yaren R Kursunluoglu G Turgut 2007 MDR1 C3435T polymorphism in patients with breast cancer Arch Med Res 38 539 544
23. F Tatari 2009 Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population DNA Cell Biol 28 259 263
24. OB Goreva AY Grishanova OV Mukhin NP Domnikova VV Lyakhovich 2003 Possible prediction of the efficiency of chemotherapy in patients with lymphoproliferative diseases based on MDR1 gene G2677T and C3435T polymorphisms Bull Exp Biol Med 136 183 185
25. K Jamroziak 2009 Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma Leuk Res 33 332 335
26. CF Rochlitz 1992 PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia Ann Hematol 65 241 246
27. N Guillaume 2007 Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia Leuk Lymphoma 48 1468 1469
28. D Rund I Azar O Shperling 1999 A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease Adv Exp Med Biol 457 71 75
29. K Jamroziak 2004 Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibly and clinical outcome of childhood acute lymphoblastic leukemia Eur J Haematol 72 314 321
30. H Hattori 2007 Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia Leuk Res 31 1633 1640
31. M Krajinovic D Labuda C Richier S Karimi D Sinnett 1999 Susceptibility to childhood lymphoblastic leukemia: influence of CYP1a1, CYP2D6, GSTM1 and GSTT1 genetic polymorphism Blood 93 496 1501
32. U Potocnik M Ravnik-Glavac D Glavac 2002 Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability Cell Mol Biol Lett 7 92 95
33. S Golapud S Gupta 2001 Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival J Clin Immunol 21 420 430
34. C Mattews 2006 MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVh genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia Leuk Lymph 47 2308 2313
35. A Pawlik M Baskiewicz-Masiuk B Machalinski M Kurzawski B Gawronska-Szklarz 2005 Involvement of C3435T and G 2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone Eur J Pharmacol 528 27 36
36. Li JP, Zhang CL, Han ZC. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Crit Rev Oncol Hematol. 2009. Epub ahead of print.
37. OA Tsopra PG Ziros ED Lagadinou A Symeonidis A Kouraklis-Symeonidis E Thanopoulou MK Angelopoulou TP Vassilakopoulos GA Pangalis NC Zoumbos 2009 Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha Acta Haematol 121 187 195